Literature DB >> 7998785

Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview.

G Rosati1.   

Abstract

The oversimplified but commonly accepted belief, based on the comparison of the prevalence studies conducted until 1980, that the distribution of multiple sclerosis (MS) in Europe is related to latitude has been contradicted by a great number of prevalence and incidence studies carried out since 1980. The most recent studies, based on more appropriate methods, clearly indicate that the MS distribution in Europe is much more complex than supposed in the past. The MS distribution in Europe now appears to be very uneven, with great variations not only between areas at the same latitude, but also within the countries themselves. However, even the most recent European studies cannot be reliably compared because of differences in the denominator characteristics, case ascertainment accuracy, diagnostic criteria, and definitions of prevalence and incidence. Despite these problems, descriptive data since 1980 indicate that ethnicity plays an important role in determining the European MS distribution. Furthermore, variations in both prevalence and incidence rates in ethnically homogeneous populations confirm the i importance of environmental factors in determining the primary acquisition of the disease. Further descriptive studies based on more comparable methods and better control for ethnicity would more precisely define the role of genetic susceptibility as well as suggest more valuable clues regarding environmental factors affecting the primary acquisition of MS.

Entities:  

Mesh:

Year:  1994        PMID: 7998785     DOI: 10.1002/ana.410360803

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.

Authors:  A Fourrier; B Bégaud; A Alpérovitch; M H Verdier-Taillefer; E Touzé; N Decker; J L Imbs
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

2.  Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 3.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles.

Authors:  M G Marrosu; M R Murru; G Costa; F Cucca; S Sotgiu; G Rosati; F Muntoni
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

5.  Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

Authors:  Silke Schmidt; Lisa F Barcellos; Karen DeSombre; Jacqueline B Rimmler; Robin R Lincoln; Patricia Bucher; Ann M Saunders; Eric Lai; Eden R Martin; Jeffery M Vance; Jorge R Oksenberg; Stephen L Hauser; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2002-02-11       Impact factor: 11.025

6.  Economic evaluation of multiple sclerosis in the UK, Germany and France.

Authors:  N Murphy; C Confavreux; J Haas; N König; E Roullet; M Sailer; M Swash; C Young; J L Mérot
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 7.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

Review 8.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

9.  Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.

Authors:  Saeed Rezaali; Ahad Khalilnezhad; Abdorreza Naser Moghadasi; Samira Chaibakhsh; Mohammad Ali Sahraian
Journal:  Iran J Neurol       Date:  2013

Review 10.  Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

Authors:  Cullen O'Gorman; Robyn Lucas; Bruce Taylor
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.